AbSci

View the org chart displaying its 21 main executives

Most searched biographies at AbSci

• Sean McClain, Chief Executive Officer and Director
• Joseph Sirosh, Member of the Board of Directors
• Daniel Rabinovitsj, Director

Popular executive movements at AbSci

• Menelas Pangalos has joined the company as Director  (posted on January 11 2024).
• Sarah Korman, Chief Legal Officer, has left the company  (posted on August 22 2023).
• Sarah Korman, who was Chief Legal Officer, is promoted to Chief Legal Officer and Interim Chief Business Officer  (posted on August 18 2023).

Click here to view some more movements at AbSci

Create your alert
to follow the executive moves at AbSci.

AbSci has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by AbSci

Social media about AbSci

• AbSci on Wikipedia, Google News & Yahoo Finance
• AbSci on LinkedIn, Twitter & YouTube

Contact by email its executives including Sean McClain

Call AbSci at +1 360...

View the org chart

Register to receive your alert

Report an error